Trial intelligence / Profile preview

Nestorone/Ethinyl Estradiol Vaginal Ring vs Oral Contraceptive on Hepatic Factors

NCT00213096Phase 2Completed

Sponsor
Population Council
Start
Mar 2003
Modality
Orthosteric Ligands
Countries
1
01

Overview

Phase 2, randomised, open-label trial of segesterone in pregnancy (2 arms), sponsored by Population Council. Primary endpoints: Serum Angiotensinogen at 3 months and Sex-Hormone Binding Globulin at 3 months. Started Mar 2003; status: completed.

02

Drugs

segesterone
03

Conditions

pregnancy

Beyond the preview

Go deeper on NCT00213096.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00213096.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call